Back to Benefits Insider

Prescription Drug Data Collection Filing Due June 2023 Featured Image

Prescription Drug Data Collection Filing Due June 2023

Under Section 204 (Title II, Division BB) of the Consolidated Appropriations Act, 2021 (CAA),  insurance companies and employer-based health plans must submit information about prescription drugs and health care spending. This data submission is called the “RxDC report.” The Rx stands for prescription drug and the DC stands for data collection. The RxDC report isn’t only about prescription drugs. It also collects information on health care spending and premiums paid by members and employers.

The Centers for Medicare and Medicaid Services is collecting the RxDC report on behalf of the Departments of Health and Human Services, the Department of Labor, the Department of the Treasury, and the Office of Personnel Management.

For more information, the Center for Medicare and Medicaid Services has an entire RxDC web page where you can find filing instructions, manuals, videos, frequently asked questions and more helpful resources.

Note: In preparation for the next filing for reference period of 2022, CDB will report employer and employee contributions. Our Account Management team will be reaching out to brokers and customers to confirm employer and employee contribution information.

Back to Benefits Insider